# Evaluation of the Efficacy of the Sequencing Method by Gene-panel

> **NCT02954640** · NA · COMPLETED · sponsor: **Imagine Institute** · enrollment: 115 (actual)

## Conditions studied

- Primary Immuno-Deficiencies

## Interventions

- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT02954640
- **Lead sponsor:** Imagine Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-09-08
- **Final completion:** 2017-09-08
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954640, "Evaluation of the Efficacy of the Sequencing Method by Gene-panel". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT02954640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*